• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重度吸烟的精神分裂症患者、抑郁症患者及非患者吸烟者吸烟的奖励价值。

Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers.

作者信息

Spring Bonnie, Pingitore Regina, McChargue Dennis E

机构信息

Department of Psychology, University of Illinois at Chicago, 60607, USA.

出版信息

Am J Psychiatry. 2003 Feb;160(2):316-22. doi: 10.1176/appi.ajp.160.2.316.

DOI:10.1176/appi.ajp.160.2.316
PMID:12562579
Abstract

OBJECTIVE

The study goal was to determine whether schizophrenic and depressed smokers perceive the reinforcement value of cigarette smoking differently from nonpsychiatric smokers who smoke as heavily.

METHOD

The authors assessed the preferences for smoking cigarettes versus engaging in other pleasant activities, the perceived advantages and disadvantages of smoking, and the amount of reinforcement that would be needed to attain smoking abstinence among 26 schizophrenic, 26 depressed, and 26 nonpsychiatric heavy smokers.

RESULTS

Both schizophrenic and depressed participants chose smoking as their preferred activity more often than nonpsychiatric smokers, and they did not differ from each other. The patients also exceeded the comparison group in the benefits they ascribed to smoking and felt they would require more incentives to quit, but they attributed comparable drawbacks to smoking.

CONCLUSIONS

Schizophrenic and depressed smokers recognize many drawbacks associated with smoking, but compared to nonpatients who smoke as heavily, they also perceive more benefits and find cigarettes more appealing than alternative rewards. The heightened reward value of smoking warrants attention in tailoring tobacco control interventions for schizophrenic and depressed smokers.

摘要

目的

本研究的目标是确定精神分裂症吸烟者和抑郁症吸烟者对吸烟强化价值的认知是否与重度吸烟的非精神疾病吸烟者有所不同。

方法

作者评估了26名精神分裂症患者、26名抑郁症患者和26名非精神疾病重度吸烟者在吸烟与参与其他愉悦活动之间的偏好、对吸烟利弊的认知,以及实现戒烟所需的强化量。

结果

与非精神疾病吸烟者相比,精神分裂症患者和抑郁症患者更常选择吸烟作为他们偏好的活动,且二者之间无差异。患者在吸烟的益处方面也超过了对照组,并且觉得他们需要更多激励才能戒烟,但他们认为吸烟存在类似的弊端。

结论

精神分裂症吸烟者和抑郁症吸烟者认识到与吸烟相关的许多弊端,但与重度吸烟的非患者相比,他们也认为吸烟有更多益处,并且发现香烟比其他奖励更具吸引力。吸烟的奖励价值增加值得在为精神分裂症吸烟者和抑郁症吸烟者量身定制烟草控制干预措施时予以关注。

相似文献

1
Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers.重度吸烟的精神分裂症患者、抑郁症患者及非患者吸烟者吸烟的奖励价值。
Am J Psychiatry. 2003 Feb;160(2):316-22. doi: 10.1176/appi.ajp.160.2.316.
2
Effects of cigarette smoking status on delay discounting in schizophrenia and healthy controls.吸烟状况对精神分裂症患者和健康对照者延迟折扣的影响。
Addict Behav. 2012 Jan;37(1):67-72. doi: 10.1016/j.addbeh.2011.08.012. Epub 2011 Sep 8.
3
Contingencies for change in complacent smokers.自满吸烟者改变的意外情况。
Exp Clin Psychopharmacol. 2007 Jun;15(3):245-55. doi: 10.1037/1064-1297.15.3.245.
4
Predictors of the Perception of Smoking Health Risks in Smokers With or Without Schizophrenia.有或无精神分裂症吸烟者对吸烟健康风险认知的预测因素
J Dual Diagn. 2017 Jan-Mar;13(1):29-35. doi: 10.1080/15504263.2016.1260190. Epub 2016 Nov 18.
5
Task persistence predicts smoking cessation in smokers with and without schizophrenia.任务坚持度可预测精神分裂症患者和非精神分裂症患者的戒烟成功率。
Psychol Addict Behav. 2012 Dec;26(4):850-8. doi: 10.1037/a0028375. Epub 2012 May 28.
6
Effort-based decision making varies by smoking status.基于努力的决策因吸烟状况而异。
Psychopharmacology (Berl). 2020 Apr;237(4):1081-1090. doi: 10.1007/s00213-019-05437-3. Epub 2020 Jan 3.
7
Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland.苏格兰尼斯代尔地区精神分裂症患者的吸烟习惯、当前症状及病前特征。
Am J Psychiatry. 1999 Nov;156(11):1751-7. doi: 10.1176/ajp.156.11.1751.
8
[Smoking reduction and temporary abstinence: new approaches for smoking cessation].[减少吸烟与临时戒烟:戒烟的新方法]
J Mal Vasc. 2003 Dec;28(5):293-300.
9
Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment.精神分裂症患者自我报告的吸烟动机与抗精神病药物治疗有关。
Schizophr Res. 2008 Mar;100(1-3):252-60. doi: 10.1016/j.schres.2007.11.027. Epub 2008 Jan 4.
10
Heterogeneity in the Effects of Reward- and Deposit-based Financial Incentives on Smoking Cessation.基于奖励和押金的经济激励措施对戒烟效果的异质性
Am J Respir Crit Care Med. 2016 Oct 15;194(8):981-988. doi: 10.1164/rccm.201601-0108OC.

引用本文的文献

1
Clearing the smoke: experiences of patients and professionals during a one-year smoking cessation intervention in ambulatory mental healthcare - a qualitative study.驱散烟雾:门诊精神卫生保健中为期一年的戒烟干预期间患者和专业人员的经历——一项定性研究
Subst Abuse Treat Prev Policy. 2025 Jul 25;20(1):29. doi: 10.1186/s13011-025-00663-9.
2
Baseline predictors of smoking cessation among individuals with current or past major depressive disorder following treatment with varenicline and intensive behavioral treatment.在接受伐尼克兰治疗和强化行为治疗后,患有当前或既往重度抑郁症的个体戒烟的基线预测因素。
Drug Alcohol Depend. 2025 Sep 1;274:112761. doi: 10.1016/j.drugalcdep.2025.112761. Epub 2025 Jun 21.
3
Nicotine's Effects on Schizophrenia-like Symptoms in a Mice Model: Time Matters.
尼古丁对小鼠模型中精神分裂症样症状的影响:时间很重要。
Brain Sci. 2024 Aug 25;14(9):855. doi: 10.3390/brainsci14090855.
4
Smoking may increase the usage of antidepressant: evidence from genomic perspective analysis.吸烟可能会增加抗抑郁药的使用:来自基因组学视角分析的证据。
Eur Arch Psychiatry Clin Neurosci. 2025 Feb;275(1):201-208. doi: 10.1007/s00406-024-01802-2. Epub 2024 May 3.
5
The interacting effects of depression symptoms and sweet flavoring on the rewarding and reinforcing value of cigarillo use among young adults.抑郁症状与甜味剂对年轻成年人小雪茄使用的奖赏及强化价值的交互作用。
Drug Alcohol Depend Rep. 2024 Apr 9;11:100234. doi: 10.1016/j.dadr.2024.100234. eCollection 2024 Jun.
6
Establishing associated risk factors, including fungal and parasitic infections among Malaysians living with schizophrenia.确定与马来西亚精神分裂症患者相关的风险因素,包括真菌感染和寄生虫感染。
Sci Rep. 2024 Jan 3;14(1):385. doi: 10.1038/s41598-023-50299-7.
7
Depression Severity Moderates Reward Learning Among Smokers With Current or Past Major Depressive Disorder in a Smoking Cessation Randomized Clinical Trial.在一项戒烟随机临床试验中,抑郁严重程度对患有当前或过去重度抑郁症的吸烟者的奖赏学习有调节作用。
Nicotine Tob Res. 2024 Apr 22;26(5):639-644. doi: 10.1093/ntr/ntad221.
8
Seeing Through the Blind: Belief About Treatment Randomization and Smoking Cessation Outcome Among People With Current or Past Major Depressive Disorder Who Smoke in a Placebo-Controlled Trial of Varenicline.看穿盲目:在一项关于伐尼克兰的安慰剂对照试验中,当前或过去患有重度抑郁症且吸烟的人群对治疗随机化的认知与戒烟结果
Nicotine Tob Res. 2024 Apr 22;26(5):597-603. doi: 10.1093/ntr/ntad218.
9
Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trial.有或曾患有重性抑郁障碍的个体中,联合行为激活治疗戒烟和伐伦克林治疗烟草依赖的疗效和安全性:一项 2×2 析因、随机、安慰剂对照试验。
Addiction. 2023 Sep;118(9):1710-1725. doi: 10.1111/add.16209. Epub 2023 May 3.
10
Treatment adherence in a smoking cessation clinical trial for individuals with current or past major depressive disorder: Predictors and association with cessation.有或曾患有重度抑郁症个体的戒烟临床试验中的治疗依从性:预测因素及其与戒烟的关联。
Addict Behav. 2023 Aug;143:107686. doi: 10.1016/j.addbeh.2023.107686. Epub 2023 Mar 5.